| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,677,077 | 2,603,643 | 1,982,148 | | Cost of Revenue | 1,608,108 | 1,699,785 | 1,126,894 | | | Gross Profit | 1,068,969 | 903,858 | 855,254 | | | Operating Expenses | | Research Development | 672,511 | 655,224 | 413,432 | | Selling General and Administrative | 406,875 | 381,409 | 255,569 | | Non Recurring | 585,303 | 2,358,456 | (4,143) | | Others |
-
|
-
| 32,089 | | | | Total Operating Expenses |
-
|
-
| 696,947 | | | | Operating Income or Loss | (595,720) | (2,491,231) | 158,307 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 36,110 | 46,762 | 51,277 | | Earnings Before Interest And Taxes | (559,610) | (2,444,469) | 209,584 | | Interest Expense | 34,943 | 31,020 | 24,263 | | Income Before Tax | (594,553) | (2,475,489) | 185,321 | | Income Tax Expense | 27,700 | 11,326 | 15,682 | | Minority Interest |
-
| (4) | (1) | | | | Net Income From Continuing Ops | (622,253) | (2,486,819) | 169,638 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (622,253) | (2,486,819) | 169,638 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($622,253) | ($2,486,819) | $169,638 |
|
0.16% Nasdaq 0.00%
Income Statement
